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Background: Epidurally administered dexamethasone may reduce the incidence and severity of postoperative 
pain. We investigated whether postoperative pain could be alleviated by preoperative or postoperative epidural 
dexamethasone administration in patients undergoing major abdominal surgery.
Methods: Ninety patients (age 30-77 with American Society of Anesthesiologists physical status I and II) undergoing 
radical subtotal gastrectomy were randomly allocated to three groups using computer generated randomization. 
In all groups, 10 ml of 0.25% ropivacaine was injected epidurally before the start and at the end of the operation. 
In Group I, a bolus ropivacaine epidural without dexamethasone was administered. In Group II, dexamethasone 
(5 mg) was added to the ropivacaine bolus epidural before the start of operation. In Group III, the same amount of 
dexamethasone was given with the ropivacaine epidural at the end of operation. Effort and resting VAS, the use of 
rescue analgesics and any complications noted during the procedure were evaluated. 
Results: VAS and requirements of rescue analgesics were significantly lower in Groups II and III when compared to 
Group I. There were no difference in the incidence of nausea and vomiting between groups, but an itching sensation 
was frequent in Group III. 
Conclusions: The administration of 5 mg of dexamethasone epidurallly, before or after operation, could reduce the 
pain and analgesic requirement after radical subtotal gastrectomy. (Korean J Anesthesiol 2011; 61: 233-237)
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Introduction
Adequate postoperative pain control can improve post-
operative recovery and reduce morbidity.
Several adjuvants have been used to enhance analgesia 
and prolong the analgesic duration, as well as reduce opioid 
requirements and related side effects.
Corticosteroids have a powerful anti-inflammatory action 
and have demonstrated reduced pain and swelling after various 
surgeries, but the exact mechanism of the analgesic effect is 
not fully understood [1,2]. Steroids are also known to inhibit 
phospholipase A2 and the expression of cyclooxygenase-2 
during inflammation. Thus, reduced prostaglandin synthesis 
suppresses hyperalgesia associated with acute nociception 
during surgery [3]. Although steroids given epidurally were 
effective in the treatment of lower back pain [4], in addition to 
reducing postoperative pain and analgesic requirements [5], 
the potential efficacy of postoperative analgesia has not been 
elucidated. 
This study was designed to investigate whether postoperative 
pain could be alleviated by epidural administration of dexam-
etha  sone in patients undergoing major abdominal surgery. 
Materials and Methods
This randomized controlled study was approved by the 
insti  tutional review board and written informed consent was 
obtained from all study participants. Ninety patients (age 30-
77 and having American Society of Anesthesiologists physical 
status I and II) scheduled for radical subtotal gastrectomy due 
to stomach cancer by a single surgeon were included to this 
study from June 2009 to July 2010. Patients with a history of 
cardiac, respiratory, neuromuscular, hepatic or major renal 
disease were excluded from this study. Patients were also 
excluded if they were obese, diabetic, had local infection, 
spinal anomalies, infectious diseases, neurologic disorders, 
seizures and coagulopathies or if they were receiving analgesics, 
corticosteroids or calcium channel blocking drugs. 
Using computer generated randomization, patients were 
allocated to three groups: Group I (n = 30, local anesthetics 
only), Group II (n = 30, epidural dexamethasone, 5 mg prior to 
surgery), and Group III (n = 30, epidural dexamethasone, 5 mg 
at the end of surgery). The patient and the investigator involved 
in the data collection were not aware of the patient group 
assignment/treatment. All drugs used for epidural injection 
(0.25% ropivacaine with 5 mg dexamethasone or same volume 
of saline) were prepared in the anesthesia preparation room by 
a nurse who was blinded to the study. Anesthetic practitioners, 
who were also blinded to the group allocation, managed the 
anesthesia. 
On arrival to the operating room, standard monitors were 
applied to the patients. Epidural paramedian puncture was 
performed at the T7-8 interspace with 17 G Touhy needle in the 
lateral decubitus position. After identifying the epidural space 
with loss of resistance technique, a 20 G multi-orifice epidural 
catheter was threaded and advanced 6 cm cephalad and safely 
fixed. Successful epidural catheterization was confirmed 
with sensory changes after a test dose of 2% lidocaine (3 ml) 
was injected. Anesthesia was induced with propofol and 
remifentanil infusion. Tracheal intubation was performed after 
rocuronium administration and anesthesia was maintained 
with sevoflurane in air/O2 (FiO2 = 0.5). Supplemental remifen-
tanil was continuously infused. In all groups, 10 ml of 0.25% 
ropivacaine was injected epidurally before the start and at 
the end of the operation. In Group I, epidural ropivacaine 
without dexamethasone was epidurally administered. In Group 
II, epidural dexamethasone (5 mg) was added to the bolus 
ropivacaine injection before the start of operation. In Group 
III, the same amount of dexamethasone was given with the 
epidural ropivacaine treatment at the end of operation. 
During surgery, the anesthetic depth was maintained within 
a range of ± 20% from baseline values for heart rate and arterial 
blood pressure and the bispectral index was maintained within a 
range of 40-60. Subtotal gastrectomy with gastroduodenostomy 
(Billoth I) surgery was then initiated. After the second bolus 
epidural injection, an infusion device (Automed-3200
Ⓡ, Ace-
medical, Seoul, Korea) prefilled with 0.15% ropivacaine and 
1,000 μg of fentanyl with a total volume of 250 ml was connected 
to the epidural catheter. The infusion device was programmed 
with a basal infusion rate of 5 ml/h without an intermittent 
bolus dose. After the surgery, the residual neuromuscular 
blockade was reversed with pyridostigmine and glycopyrrolate, 
and then 4 mg of ondansetrone was given. When the patient 
responded to verbal commands and neuromuscular function 
was ascertained by 4 responses of the adductor pollicis to train 
of four stimulation with sufficient spontaneous respiration 
determined by tidal volume and respiratory rates, the tracheal 
tube was removed. In the post-anesthesia care unit (PACU), 
postoperative pain was assessed using the visual analog scale 
(VAS) score at rest and with effort (i.e. coughing and at 30
o 
sitting) at 5 minutes (T1) and 30 minutes (T2) after entry. 
When the patient requested an analgesic, 50 μg of fentanyl was 
administered i.v. in the PACU. After discharge from the PACU, 
two nurse investigators blinded to the study groups assessed the 
pain scores 24 h (T3) and 48 h (T4) after surgery. The incidence 
of adverse effects, such as peripheral oxygen desaturation (SpO2 
< 90%), nausea or vomiting, somnolence, and pruritus (rubbing 
or scratching the skin) were recorded. Patients were instructed 
to request analgesics from the nurse when needed. Meperidine 
(25 mg, i.v.) was given as the rescue analgesic. 235 www.ekja.org
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All data were analyzed with PASW Statistics 18
Ⓡ (SPSS Inc., 
Chicago, IL, USA). Continuous variables were shown as mean ± 
SD and categorical variables were shown as numbers. A series 
of one-way ANOVAs were conducted to examine differences 
among the 3 groups with respect to parametric variables 
followed by student’s t test. Categorical variables were analyzed 
using the chi-square test or Fisher’s exact test, as appropriate. A 
P value of <0.05 was considered significant.
Results
There were no significant differences in patient characte-
ristics between groups (Table 1). The resting VAS was signifi-
cantly lower in Group II at T2 compared to Group I. In Group 
III, the resting VAS was significantly lower at T2, T3, and T4 than 
in Group I. The effort VAS was significantly lower in Group III 
than in Group I at T3 and T4 (Fig. 1).
Postoperative rescue analgesic requirements and adverse 
effects are shown in Table 2. In the PACU, fentanyl was given 
in 11 patients in Group I, 4 in Group II, and 7 in Group III and 
there were no significant differences in the total amount of 
Fig. 1. Resting and effort visual analogue scale (VAS). T1: 5 min after arrival in post-anesthetic care unit, T2: discharge time from the post-
anesthetic care unit, T3: 24 h after the operation, T4: 48 h after the operation. *P < 0.05 vs. Group I. 
Table 1. Patient Characteristics
Group I
(n = 30)
Group II
(n = 30)
Group III
(n = 30)
Age (yr)
Sex (M/F)
Weight (kg)
Height (cm)
Operation time (min)
Anesthesia time (min)
Intake fluid (ml)
Urine output (ml)
56 ± 10
22/8
63 ± 8
167 ± 7
196 ± 58
225 ± 63
1,289 ± 500
266 ± 159
58± 12
22/8
61 ± 10
165 ± 7
175 ± 60
205 ± 55
1,363 ± 595
196 ± 180
57 ± 9
20/10
63 ± 9
164 ± 6
185 ± 58
222 ± 56
1,274 ± 410
256 ± 219
Data are expressed as mean ± SD or as number of patients. 
Table 2. Postoperative Rescue Analgesic Requirement and Adverse Effects 
Group I
(n = 30)
Group II
(n = 30)
Group III
(n = 30)
P value
Rescue analgesic requirements
    Fentanyl in PACU (n)
    Postoperative 24 h (n)
    Postoperative 48 h (n)
Total amount of rescue analgesics
    Fentanyl in PACU (ug)
    Meperidine 24 h (mg)
    Meperidine 48 h (mg)
    Time to 1
st rescue analgesics (hr)
Adverse effect
    PONV
    Somnolence
    Pruritus
11
21
14
18 ± 25
42 ± 40
23 ± 31
20 ± 19
  0
  1
  1
  4
    8*
17
10 ± 24
13 ± 30*
23 ± 27
30 ± 15*
  2
  0
  1
7
8*
19
15 ± 23
14 ± 25*
21 ± 19
32 ± 15*
0
0
6*
0.108
<0.001
0.444
0.358
0.001
0.923
0.015
0.129
0.370
0.032
Data are expressed as mean ± SD or as number of patients (%).  PONV: postoperative nausea and vomiting. *P < 0.05 vs. Group I.236 www.ekja.org
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rescue fentanyl (P = 0.358). The total requirements of rescue 
meperidine were significantly less in Groups II and III as 
compared to Group I at postoperative 24 h (P = 0.001) but, there 
were no significant differences at postoperative 48 h (P = 0.923). 
No significant differences were found in the incidence of nausea 
and vomiting between the groups. The frequency of pruritus 
was higher in Group III compared to Groups I and II (Table 2). 
No one showed peripheral oxygen desaturation (SpO2 < 90%) 
throughout the study period.
Discussion
In patients undergoing gastrectomy, high thoracic epidural 
catheterization is commonly performed to provide continuous 
postoperative pain control. In spite of continuous epidural pain 
control, some patients frequently request additional analgesics. 
In our study, rescue analgesics were required in 8.9% of patients 
within 5 minutes of arrival in the PACU, in 15.6% by 30 minutes, 
in 41% within 24 h and in 55.6% by postoperative hour 48. 
Epidural steroid injection is a common modality for treat-
ment of chronic pain. Dexamethasone has been demonstrated 
to reduce lumbar epidural puncture-induced backache [4], 
post  operative pain, and morphine consumption [5]. We con-
ducted this study to assess the effects of epidurally admini-
stered dexamethasone on postoperative analgesia after major 
abdominal surgery. Although the underlying mechanism(s) 
of epidural steroid and local anesthetics are still not well 
under  stood, it is considered that the neural blockade alters 
or interrupts nociceptive input, reflex mechanisms of the 
afferent fibers, self-sustaining neuronal activity and the pattern 
of central neuronal activities [6]. In addition, steroids reduce 
inflammation by inhibiting either the synthesis or release of a 
several pro-inflammatory mediators and by causing a reversible 
local anesthetic effect. Epidural dexamethasone administration 
has been shown to reduce postoperative analgesic require-
ments in dental, laparoscopic and breast surgeries [7-10]. 
However, there have been no studies investigating the effect 
of epidural dexamethasone treatment on pain after major 
abdominal surgery. The major finding of this study was that 5 
mg of epidurally administered dexamethasone was effective in 
reducing the degree of pain and rescue analgesic requirements 
after radical subtotal gastrectomy during the early postoperative 
period. 
Acute noxious stimulation of peripheral tissues leads to 
sensitization of dorsal horn neurons of the spinal cord by 
the release of excitatory amino acids such as glutamate and 
aspartate. These amino acids activate N-methyl-D-aspartate 
receptors resulting in calcium ion influx. As a result, increased 
intracellular calcium activates phospholipase A2 which converts 
membrane phospholipids to arachidonic acid. Simultaneously, 
there is up-regulation of the expression of cyclo-oxygenase 2 
in the spinal cord, leading to prostaglandin E2 synthesis, which 
results in a hyperalgesic state [1,3]. Epidural dexamethasone 
administration may influence intraspinal prostaglandin 
synthesis by inhibiting phospholipase A2 and the expression of 
cyclo-oxygenase 2 [1]. Steroids also suppress transmission in 
thin unmyelinated C-fibers and bind directly to the intracellular 
glucocorticoid receptor [11]. 
The exact onset time of dexamethasone is unclear and the 
appropriate timing for administration is still controversial. 
Some have reported preoperative administration of epidural 
dexamethasone reduces postoperative pain and analgesic 
requirements [5,12]. Tissue injured during surgery acts as 
an acute noxious stimulation to other tissues. Thus, it leads 
to activation of phospholipase A2 and the expression of 
cyclooxygenase 2 in the spinal cord, resulting in prostaglandin 
synthesis and induction of a hyperalgesic state [3]. Preoperative 
administration of steroids may reduce these reactions and 
improve analgesia [9]. In a recent meta-analysis, preoperative 
or postoperative epidural steroid treatment decreased pain 
and shortened the length of hospital stays after lumbar spinal 
surgery [13]. In our study, the preoperative dexamethasone 
group (Group II) had a low resting VAS after 30 min in the PACU 
and the postoperative dexamethasone group (Group III) had 
a low resting VAS after 30 min of PACU as well as 24 and 48 h 
postoperatively. Effort VAS for Group II was also significantly 
higher than in Group III and there was no difference when 
compared to Group I. 
Because we could not rule out the possible bias in pain 
assessment, we evaluated the number of rescue analgesic 
requirements and total amount of rescue opioid used. The 
time to the first rescue analgesic requirement was longer and 
the total amount of rescue meperidine used during the first 24 
h of the postoperative period was less in the dexamethasone-
treated groups (Group II and III) than in the group not receiving 
dexamethasone (Group I). Although we could not conclude the 
proper time to administer epidural dexamethasone because 
pain is very subjective and affected by many factors, epidural 
dexamethasone administration may alleviate the pain after 
major abdominal surgery. 
The incidence of postoperative nausea and vomiting as well 
as somnolence was not significantly different between groups. 
However, the frequency of an itching sensation was higher in 
Group III. Ironically, i.v. dexamethasone-induced perineal 
pruritus has been described in patients with chemotherapy and 
acute head injury in an attempt to reduce intracranial pressure 
and oral surgery [14-16]. This adverse effect can be prevented 
by slowly giving diluted dexamethasone [17]. Also, because 
intrathecally or epidurally administered opioid-induced 
pruritus is not associated with histamine release, H1 blockers 237 www.ekja.org
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have little effect on the development of pruritus after opioid 
administration [18,19]. In our study, no one showed perineal 
pruritus and all symptoms of pruritus were relieved by the 
administration of diphenhydramine. 
In conclusion, the epidural administration of 5 mg of 
dexamethasone can reduce the pain and rescue analgesic 
requirements 24 h after radical subtotal gastrectomy. Further 
study is required for determination of the proper timing of 
dexamethasone administration. 
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